Overview
Neha Nanda is an Infectious Disease provider in Los Angeles, California. Her top areas of expertise are Severe Acute Respiratory Syndrome (SARS) and COVID-19.
Her clinical research consists of co-authoring 18 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
1500 San Pablo St, Los Angeles, CA 90033
5 Columbus Cir, New York, NY 10019
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UC Regents UCLA DMPG Century City
Jeffrey Klausner is an Infectious Disease provider in Los Angeles, California. Dr. Klausner is highly rated in 15 conditions, according to our data. His top areas of expertise are Gonorrhea, Syphilis, Chlamydia, and HIV/AIDS.
Antaki And Associates Infectious Disease Medical Group., Inc.
I seek to provide the most complete care to my patients in a caring and respectful way. Dr. Antaki is highly rated in 35 conditions, according to our data. His top areas of expertise are Pneumonia, Hospital-Acquired Pneumonia, Sepsis, and COVID-19.
Torrance Health Association Inc.
James Mckinnell is an Infectious Disease provider in Torrance, California. Dr. Mckinnell has been practicing medicine for over 22 years is highly rated in 12 conditions, according to our data. His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), COVID-19, Sepsis, Multisystem Inflammatory Syndrome in Children (MIS-C), and Coronary Artery Bypass Graft (CABG).
Frequently Asked Questions about Dr. Neha Nanda
How do I make an appointment with Dr. Neha Nanda?
You can book an appointment with Dr. Neha Nanda by calling their office at 323-442-8500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Neha Nanda a top-rated expert for Severe Acute Respiratory Syndrome (SARS)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Neha Nanda is classified as an Experienced expert for Severe Acute Respiratory Syndrome (SARS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Neha Nanda specialize in?
While Dr. Neha Nanda is a Infectious Disease, they have specific expertise in Severe Acute Respiratory Syndrome (SARS), COVID-19. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.
Does Dr. Neha Nanda participate in research or clinical trials?
Yes. Dr. Neha Nanda has published 18 articles and abstracts on conditions like Severe Acute Respiratory Syndrome (SARS). You can view a list of Dr. Neha Nanda's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Neha Nanda accept my insurance?
Dr. Neha Nanda accepts most major insurance plans, including Humana. We recommend calling the office directly at 323-442-8500 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Dr. Nanda isExperienced. Learn about COVID-19.
- Severe Acute Respiratory Syndrome (SARS)